MeSH

All of the processes involved in increasing CELL NUMBER including CELL DIVISION.

Year introduced: 2005

produced by thymus cells, following treatment with antilymphocyte serum; inhibits colony formation by bone marrow cells; possesses no antiviral activity

Date introduced: January 1, 1979

A cellular transcriptional coactivator that contains N-terminal KELCH REPEATS and N- and C-terminal FIBRONECTIN TYPE III DOMAINS. It functions as a transcription factor for a number of genes and in the assembly of IMMEDIATE-EARLY PROTEINS of the HERPES SIMPLEX VIRUS. Mutations in the HCFC1 gene are associated with cases of X-LINKED MENTAL RETARDATION.

Year introduced: 2006(1995)

encoded a protein of about 104 kDa; URG4 was strongly expressed in hepatitis B-infected liver and in HCC cells; RefSeq NM_017920

Date introduced: February 11, 2003

GenBank L08909

Date introduced: June 5, 1995

RefSeq NM_001018025

Date introduced: September 24, 1993

A spectrum of primary, secondary, and idiopathic disorders involving MAST CELLS and characterized by an aberrant release of mast cell mediators which result in multiple and variable inflammatory and allergic symptoms. These disorders are associated with various mutations in tyrosine kinase KIT (PROTO-ONCOGENE PROTEINS C-KIT) and other genes, underlying conditions, and responses to allergic or non-allergic triggers of mast cell stimulation and degranulation such as local anesthetics, lactam antibiotics, muscle relaxants, specific foods, environmental toxins, physical conditions such as vibration, cold, pressure, and stress.

Year introduced: 2022